Todd C Davis's Net Worth

$7.07 Million

Estimate Recalculated Apr 26, 2024 05:37PM EST

Who is Todd C Davis?

Todd C Davis has an estimated net worth of $7.07 Million. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, ARTES MEDICAL INC, LIGAND PHARMACEUTICALS INC, and Vaxart, Inc..

SEC CIK

Todd C Davis's CIK is 0001392029

Past Insider Trading and Trends

2022 was Todd C Davis's most active year for acquiring shares with 9 total transactions. Todd C Davis's most active month to acquire stocks was the month of July. 2022 was Todd C Davis's most active year for disposing of shares, totalling 5 transactions. Todd C Davis's most active month to dispose stocks was the month of July. 2022 saw Todd C Davis paying a total of $313,881.60 for 299,837 shares, this is the most they've acquired in one year. In 2019 Todd C Davis cashed out on 218,123 shares for a total of $1,222,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIODELIVERY SCIENCES INTERNATIONAL INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-252.21K
—
—
0
Mar 22
Form 4
+3.14%
7.68K
—
—
252.21K
Jan 27
Form 4
+13.98%
30K
—
—
244.52K
Aug 6
Form 4
-18.66%
-50.00K
$4.99
-$249,500.00
217.91K
Aug 18
Form 4
+12.61%
30K
—
—
267.91K
Aug 7
Form 4
-45.67%
-200.00K
$6.11
-$1,222,000.00
237.91K
Nov 15
Form 4
+4.32%
18.12K
—
—
437.91K
Aug 13
Form 4
+13,337.61%
416.67K
—
—
419.79K
Aug 24
Form 4
∞
3.12K
—
—
3.12K
Aug 14
Form 4
—
0
—
—
0
Aug 1
Form 3
—
0
—
—
0
No matching records found

ARTES MEDICAL INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Feb 12
Form 3
—
0
—
—
0
No matching records found

LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $74.72

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+15.38%
16.02K
$57.39
$919,147.00
120.16K
Mar 25
Form 4
+45.23%
32.44K
—
—
104.14K
Feb 27
Form 4
-1.89%
-1.38K
$74.65
-$103,091.65
71.71K
Feb 15
Form 4
+5.79%
4K
$59.38
$237,528.80
73.09K
Sep 22
Form 4
-0.60%
-420.00
$73.76
-$30,979.20
69.09K
Jun 9
Form 4
+32.84%
17K
—
—
68.79K
Feb 23
Form 4
—
0
—
—
0
Dec 22
Form 4
—
0
—
—
0
Dec 5
Form 4
+1.98%
1K
—
—
51.79K
Jun 10
Form 4/A
—
0
—
—
0
Jun 19
Form 4/A
∞
5K
—
—
5K
May 31
Form 3
—
0
—
—
0
No matching records found

Vaxart, Inc. (VXRT) Snapshot price: $1.19

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.22%
7.38K
—
—
125.91K
Aug 4
Form 4
-1.23%
-1.47K
—
—
118.53K
Dec 22
Form 4
—
0
—
—
0
Jun 16
Form 4/A
—
0
—
—
0
Nov 18
Form 4
—
0
—
—
0
Jun 8
Form 4
-33.33%
-60.00K
$3.28
-$196,500.00
120K
Apr 28
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Nov 18
Form 3
—
0
—
—
0
No matching records found

Chromocell Therapeutics Corp (CHRO) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
29.17K
$4.80
$140,001.60
29.17K
Feb 21
Form 3
—
0
—
—
0
No matching records found